Susquehanna International Group
TVTX icon

Susquehanna International Group’s Travere Therapeutics TVTX Stock Holding History

Susquehanna International Group’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1M Sell
677,100
-41,300
-6% -$1.23M ﹤0.01% 2222
2025
Q4 		$27.5M Buy
718,400
+298,000
+71% +$9.69M ﹤0.01% 1903
2025
Q3 		$10M Buy
420,400
+75,800
+22% +$1.43M ﹤0.01% 3034
2025
Q2 		$5.1M Buy
344,600
+250,700
+267% +$4.16M ﹤0.01% 3928
2025
Q1 		$1.68M Sell
93,900
-22,200
-19% -$451K ﹤0.01% 5930
2024
Q4 		$2.02M Buy
116,100
+39,300
+51% +$695K ﹤0.01% 5304
2024
Q3 		$1.07M Sell
76,800
-8,500
-10% -$88.6K ﹤0.01% 6623
2024
Q2 		$701K Buy
85,300
+43,600
+105% +$294K ﹤0.01% 7415
2024
Q1 		$322K Sell
41,700
-10,500
-20% -$88.6K ﹤0.01% 9557
2023
Q4 		$469K Sell
52,200
-73,500
-58% -$535K ﹤0.01% 8830
2023
Q3 		$1.12M Buy
125,700
+66,800
+113% +$943K ﹤0.01% 6372
2023
Q2 		$905K Sell
58,900
-103,500
-64% -$1.88M ﹤0.01% 6916
2023
Q1 		$3.65M Buy
162,400
+124,400
+327% +$2.64M ﹤0.01% 3936
2022
Q4 		$799K Sell
38,000
-24,700
-39% -$523K ﹤0.01% 6672
2022
Q3 		$1.54M Buy
62,700
+5,700
+10% +$147K ﹤0.01% 5521
2022
Q2 		$1.38M Sell
57,000
-7,100
-11% -$179K ﹤0.01% 5746
2022
Q1 		$1.65M Sell
64,100
-11,400
-15% -$303K ﹤0.01% 5905
2021
Q4 		$2.34M Buy
75,500
+8,000
+12% +$225K ﹤0.01% 5131
2021
Q3 		$1.64M Buy
+67,500
New +$1.24M ﹤0.01% 6270
2021
Q2 		– Sell
-37,800
Closed -$944K – 13278
2021
Q1 		$944K Sell
37,800
-83,300
-69% -$2.3M ﹤0.01% 7896
2020
Q4 		$3.3M Buy
121,100
+24,600
+25% +$574K ﹤0.01% 4148
2020
Q3 		$1.78M Buy
96,500
+53,700
+125% +$1.04M ﹤0.01% 4846
2020
Q2 		$874K Sell
42,800
-25,900
-38% -$412K ﹤0.01% 6217
2020
Q1 		$1M Buy
68,700
+37,000
+117% +$557K ﹤0.01% 5396
2019
Q4 		$450K Sell
31,700
-55,400
-64% -$708K ﹤0.01% 7193
2019
Q3 		$1.01M Buy
87,100
+23,300
+37% +$385K ﹤0.01% 5666
2019
Q2 		$1.28M Buy
63,800
+29,300
+85% +$579K ﹤0.01% 5117
2019
Q1 		$781K Sell
34,500
-320,900
-90% -$7.09M ﹤0.01% 5475
2018
Q4 		$8.04M Sell
355,400
-7,400
-2% -$184K ﹤0.01% 1806
2018
Q3 		$10.4M Buy
362,800
+345,700
+2,022% +$9.88M ﹤0.01% 1887
2018
Q2 		$466K Sell
17,100
-29,500
-63% -$786K ﹤0.01% 6931
2018
Q1 		$1.04M Sell
46,600
-22,200
-32% -$529K ﹤0.01% 5153
2017
Q4 		$1.45M Sell
68,800
-16,500
-19% -$377K ﹤0.01% 4523
2017
Q3 		$2.12M Sell
85,300
-9,800
-10% -$216K ﹤0.01% 3791
2017
Q2 		$1.84M Buy
95,100
+11,700
+14% +$212K ﹤0.01% 4052
2017
Q1 		$1.54M Sell
83,400
-132,500
-61% -$2.59M ﹤0.01% 4213
2016
Q4 		$4.09M Sell
215,900
-29,400
-12% -$601K ﹤0.01% 2755
2016
Q3 		$5.49M Sell
245,300
-28,800
-11% -$548K ﹤0.01% 2134
2016
Q2 		$4.88M Buy
274,100
+79,500
+41% +$1.29M ﹤0.01% 2230
2016
Q1 		$2.66M Buy
194,600
+7,300
+4% +$111K ﹤0.01% 3242
2015
Q4 		$3.61M Buy
187,300
+84,600
+82% +$1.69M ﹤0.01% 2992
2015
Q3 		$2.08M Sell
102,700
-126,500
-55% -$3.75M ﹤0.01% 4199
2015
Q2 		$7.6M Sell
229,200
-367,400
-62% -$10.1M ﹤0.01% 2337
2015
Q1 		$14.3M Buy
596,600
+498,800
+510% +$7.61M 0.01% 1531
2014
Q4 		$1.2M Buy
97,800
+66,700
+214% +$690K ﹤0.01% 5501
2014
Q3 		$281K Buy
+31,100
New +$366K ﹤0.01% 8129

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group's TVTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Travere Therapeutics (TVTX) stake by 38% in Q1 2026, selling an estimated $745K and leaving 40,058 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #7437.

Susquehanna International Group first reported a position in TVTX in Q4 2014 and has held it in 28 quarters since. The position peaked at $2.9M in Q1 2023. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Susquehanna International Group held 40,058 shares of Travere Therapeutics worth $1.19M as of Q1 2026.
  • Susquehanna International Group sold 24,914 Travere Therapeutics shares in Q1 2026, an estimated $745K.
  • Travere Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7437 holding.
  • Susquehanna International Group first reported a position in Travere Therapeutics in Q4 2014 and has held it in 28 quarters since.
  • Susquehanna International Group's Travere Therapeutics position peaked at $2.9M in Q1 2023.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.